Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
adenocarcinoma, adjuvant, AEs, afflicted, Agreementswith, al, antigen, antipyretic, apatinib, biomarker, bispecific, boost, borrow, borrowing, Brenneret, carcinosarcoma, characteristic, China, classical, Cloughesyet, colorectal, concomitant, constantly, contradictory, CRADA, Dec, Deciphera, developmental, disaster, discontinuationor, ESOP, EU, evergreen, evolve, expedient, FD, filer, Fisher, float, furlough, GCIG, GMP, headquarter, HengRui, HR, Hubei, IATI, Iftekhar, imaging, induction, infection, ingested, Krishnansu, Ledermann, mAb, Mahmood, mechanistic, motor, mullerian, myeloid, NCI, neuro, Nira, niraparib, nonpublic, Notably, Oncol, operateand, Oppenheimer, outbreak, pandemic, Papillary, prognostic, Province, QP, Rachel, ratified, reaction, reconvened, recovery, reliant, replicate, ripple, Simultaneously, starvation, strain, Tewari, TheCompany, Thermo, top, transient, UCL, umbrella, undertaken, undiscounted, veliparib, wildfire, Wuhan
Removed:
accumulate, Addendum, ahead, allotted, alpha, assay, assumption, attenuation, back, billion, BioClinica, budgeted, building, cediranib, Cellular, Chardan, chosen, concurred, Cutback, Dana, discount, durable, earliest, Efficiency, EMEA, enacting, Encap, ending, exceeded, exceeding, Farber, flow, forecasting, gaining, GmbH, golden, gradual, introducing, Jecheskiel, JMP, John, Jumpstart, KCR, Konz, Lee, Matzlawi, measure, month, nonbinding, nonmarket, Oxley, parachute, payroll, Philip, piggyback, placement, potency, preference, registering, registrable, revised, SCIderm, Serlin, smaller, SOX, statistically, stream, subjective, subtracting, summarize, Thai, therewith, underwriter
Filing tables
Filing exhibits
Associated NTBL transcripts
NTBL similar filings
Filing view
External links
Exhibit 15.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statements on Form S-8 (Nos. 333-202463, 333-210583, 333-219969, 333-223232 and 333-232391) and on Form F-3 (Nos. 333-207250 and 333-222138) of Vascular Biogenics Ltd. of our report dated March 19, 2020 relating to the financial statements, which appears in this Form 20-F.
/s/ Kesselman & Kesselman | |
Tel-Aviv, Israel | Kesselman & Kesselman |
March 19, 2020 | Certified Public Accountants (Isr.) |
A member firm of PricewaterhouseCoopers International Limited |